Abcam competitors

Abcam Competitors include Humanigen, TxCell, Foundation Medicine and Biotix.
Add company...
Abcam
Abcam is a producer and distributor of research-grade antibodies and associated products.
Humanigen
Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science.
TxCell
TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Biotix
Biotix is a manufacturer of laboratory consumable tools and liquid handling solutions.
Founding Date
Founding Date
1998
Founding Date
2000
Founding Date
2001
Founding Date
2010
Founding Date
2005
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Milton, GB HQ
Sydney, AU
Shanghai, CN
Hangzhou, CN
Chuo, JP
Tokyo, JP
Bristol, GB
see more
Locations
Brisbane, US HQ
Locations
Valbonne, FR HQ
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Employees
Employees
9487% increase
Employees
433% decrease
Employees
496% decrease
Employees
535
Employees
881% increase
Valuation ($)
Valuation ($)
2.7 b
Valuation ($)
86.7 m
Valuation ($)
36.4 m
Valuation ($)
5.1 b
Valuation ($)
N/A
Facebook likes
Facebook likes
7.6 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
278
Facebook likes
446
Twitter followers
Twitter followers
4.8 k
Twitter followers
N/A
Twitter followers
334
Twitter followers
5.6 k
Twitter followers
37

Financial

Revenue (est.)
Revenue (est.)
£217.1m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
€2.2m (FY, 2017)
Revenue (est.)
$91.7m (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
£42.4m (FY, 2017)
Net income
($22m) (FY, 2017)
Net income
(€10.9m) (FY, 2017)
Net income
($161.5m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 78.8m
Total funding raised
$ 124.2m
Total funding raised
$ 70.2m
Total funding raised
$ 96.5m
Total funding raised
$ 4.2m
For sources of this data, please see the company profileDownload Excel

View company profiles

Humanigen
HQ
Brisbane, US
Employees
4↓ 33% decrease

Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science.

View company
TxCell
HQ
Valbonne, FR
Employees
49↓ 6% decrease

TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.

View company
Foundation Medicine
HQ
Cambridge, US
Employees
535

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

View company
Biotix
HQ
San Diego, US
Employees
88↑ 1% increase

Biotix is a manufacturer of laboratory consumable tools and liquid handling solutions.

View company